Table 8.
Hematological And Biochemical Parameters
| Visits | Placebo (n=23) | E-OA-07 (n=21) | ||||
|---|---|---|---|---|---|---|
| Mean (SD) | 95% CI | Mean (SD) | 95% CI | |||
| Min | Max | Min | Max | |||
| Hemoglobin (g/dl) | ||||||
| Day 0 | 12.50 (0.92) | 10.9 | 15.0 | 12.95 (1.66) | 9.6 | 16.3 |
| Day 56 | 12.58 (1.03) | 11.1 | 15.1 | 13.20 (1.66) | 10.0 | 16.4 |
| p value* | 0.385 | 0.321 | ||||
| Red Blood Cells (RBC) Count (mil/cmm) | ||||||
| Day 0 | 4.50 (0.40) | 3.44 | 5.20 | 4.66 (0.64) | 3.31 | 5.97 |
| Day 56 | 4.57 (0.51) | 2.98 | 5.60 | 4.75 (0.60) | 3.88 | 6.21 |
| p value* | 0.322 | 0.295 | ||||
| White Blood Cells (WBC) Count (mil/cmm) | ||||||
| Day 0 | 8669.57 (2327.39) | 4900 | 12,000 | 7485.00 (1401.98) | 4600 | 10,300 |
| Day 56 | 9004.35 (2779.06) | 5400 | 16,100 | 8352.38 (1651.55) | 5000 | 11,200 |
| p value* | 0.685 | 0.036 | ||||
| Platelet Count (per cmm) | ||||||
| Day 0 | 291,086.96 (68,425.08) | 141,000 | 467,000 | 270,350.00 (72,955.12) | 112,000 | 455,000 |
| Day 56 | 294,521.74 (75,998.73) | 152,000 | 403,000 | 275,380.95 (63,242.77) | 128,000 | 354,000 |
| p value* | 0.194 | 0.668 | ||||
| Serum Glutamic-Oxaloacetic Transaminase (SGOT)(U/L) | ||||||
| Day 0 | 19.64 (6.87) | 9.8 | 37.8 | 20.15 (7.26) | 12.1 | 44.9 |
| Day 56 | 20.87 (7.52) | 10.1 | 36.2 | 21.71 (7.74) | 13.9 | 43.2 |
| p value* | 0.354 | 0.651 | ||||
| Serum Glutamic-Pyruvic Transaminase (SGPT) (U/L) | ||||||
| Day 0 | 19.02 (9.10) | 8.9 | 45.2 | 19.12 (9.31) | 5.5 | 35.8 |
| Day 56 | 19.35 (8.77) | 8.9 | 42.1 | 20.47 (9.74) | 9.1 | 40.7 |
| p value* | 0.495 | 0.958 | ||||
| High sensitivity C-Reactive Protein (hs-CRP) | ||||||
| Day 0 | 3.79 (3.43) | 2.31 | 5.27 | 3.18 (2.86) | 1.88 | 4.48 |
| Day 56 | 4.65 (6.09) | 2.02 | 7.29 | 3.86 (4.00) | 2.04 | 5.68 |
| p value* | 0.438 | 0.455 | ||||
Note: *P, Wilcoxon Signed Rank test.
Abbreviations: n, number of participants; SD, standard deviation; CI, confidence interval; Min, minimum and Max, maximum.